Quantics can provide all the standard PK analysis and reporting required for drug development.

In early phase clinical trials, it is key to establish the relationship between the pharmacokinetics and pharmacodynamics of a compound. At Quantics, we provide expert advice and analysis to answer the critical questions relating to pharmacokinetics within early phase drug development.

At Quantics we have expertise in the following:

• Input into trial design
• Sample size calculations based on relevant PK parameters
• Statistical analyses of key pharmacokinetic parameters in single or multiple dose studies, crossover or sequential designs.
• Analyses of dose proportionality, bioequivalence, bioavailability
• Provision of fast turnaround interim PK results
• High-quality graphics to help visualise the impact of the compound
• Extension of pharmacokinetics into toxicokinetics